𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Abstracts of oral presentations

✍ Scribed by Wolschrijn, Hilka ;Bruring, Dot P. ;Sirpa, Peura ;Coombes, J. A. ;Horne, R. ;Blom, AhG ;Bakker, A. ;Jonkers, R. ;Strømnes, Bjørg ;Adams, P. R. ;Luscombe, D. K. ;Woods, F. J. ;Mil, J. W. Foppe ;Simiaer, K. L. ;Yorke, D. A. ;Rowe, P. ;Timmer, J. W. ;Snelling, Melanie ;Smith, Cheryl ;Luscomhe, David ;Herholdt, Annette ;Bador, P. ;Picard, A. ;Belbenoit, P. ;Locher, F. ;Grosset-Grange, I. ;Cortés, E. ;Cuesta, T. ;Ferré, P. ;Daly, M. J. ;Baxter, H. ;Swallow, R. ;Taggiasco, N. ;Samit, B. ;Beuzon, S. ;Doreau, C. ;Blake, J. ;Godman, B. ;Frias, Sara ;Scroccaro, G. ;Olivato, R. ;Messori, A. ;Casara, M. ;Martini, N. ;Hardman, Colin ;Husson, M. C. ;Shashkova, Galina V.


Publisher
Springer
Year
1993
Tongue
Dutch
Weight
562 KB
Volume
15
Category
Article
ISSN
1573-739X

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Abstracts of oral presentations
📂 Article 📅 2005 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 126 KB

The right 3D-conformation of a peptide, is essential for its biological activity. Nature has found many elegant ways to reduce the flexibility of peptides/proteins in order to control their folding and shape for increasing affinity as well as selectivity for receptor interaction. Disulfide bridges,

Abstracts of Oral Presentations
📂 Article 📅 2003 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 243 KB

Hepatitis C virus (HCV) infection is the leading cause of chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma. It has been estimated that 3% of the world population is infected with this virus and the current available treatments are of limited efficacy. One of the most intensively stud

Oral presentations
📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 463 KB

Leading clinicians from around the world will present the most recent clinical and scientific advances affecting the field of liver transplantation. They will focus on three areas: i. Management advances in hepatobiliary malignancies, particularly hepatocellular carcinoma and cholangiocarcinoma ii.